Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate

The endocannabinoid system (ECS), a signalling network with immunomodulatory properties, is a potential therapeutic target in multiple sclerosis (MS). Dimethyl fumarate (DMF) is an approved drug for MS whose mechanism of action has not been fully elucidated; the possibility exists that its therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Sanz, Alicia, Posada-Ayala, María, Sabín-Muñoz, Julia, Fernández-Miranda, Ismael, Aladro-Benito, Yolanda, Álvarez-Lafuente, Roberto, Royuela, Ana, García-Hernández, Ruth, la Fuente, Ofir Rodríguez-De, Romero, Julián, García-Merino, Antonio, Sánchez-López, Antonio José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700785/
https://www.ncbi.nlm.nih.gov/pubmed/36434122
http://dx.doi.org/10.1038/s41598-022-21807-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700785/
https://www.ncbi.nlm.nih.gov/pubmed/36434122
http://dx.doi.org/10.1038/s41598-022-21807-y

Ejemplares similares